Chem Rx Corporation Schedules Conference Call to Review Full Year 2007 Financial Results

LONG BEACH, N.Y., March 31 /PRNewswire-FirstCall/ -- Chem Rx
Corporation (OTC Bulletin Board: PMQC; PMQCU; PMQCW), a leading provider of
institutional pharmacy services, announced today that it will hold a
conference call to review 2007 financial results and discuss 2008 outlook
on April 1, 2008 at 8:30 a.m. EDT. Jerry Silva, Chairman and Chief
Executive Officer and Steven C. Silva, President and Chief Operating
Officer, will host the conference call. A press release announcing 2007
year-end results and 2008 guidance will be issued this evening.

To participate in the conference call, please dial 1-877-407-0784 (USA)
or 1-201-689-8560 (international). In addition, a dial-up replay of the
conference call will be available beginning April 1, 2008 at approximately
10:30 a.m. ET and will remain available until April 8, 2008. To access the
replay, please dial 1-877-660-6853 (USA) or 1-201-612-7415 (international)
and reference the account number 3055 and the access code 280675. A web
cast of the call will also be available from the Investor Relations section
on the corporate web site at http://www.chemrx.net through April 29, 2008.

About Chem Rx Corporation

Founded more than 40 years ago, Chem Rx Corporation is a leading
provider of institutional pharmacy services in the New York City
metropolitan area, as well as parts of New Jersey, upstate New York, and
Pennsylvania. Chem Rx's client base includes skilled nursing facilities and
a wide range of other long-term care facilities. Through its services, Chem
Rx provides more than 65,000 institutional residents with prescription and
non-prescription drugs, intravenous medications, durable medical equipment
items and surgical supplies. Chem Rx's website address is http://www.chemrx.net.

Forward Looking Statements

This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are statements that are not historical facts.
Such forward-looking statements are based upon the current beliefs and
expectations of Chem Rx's management and are subject to risks and
uncertainties that could cause actual results to differ from the
forward-looking statements. The following factors, among others, could
cause actual results to differ from those set forth in the forward-looking
statements: compliance with government regulations; changes in legislation
or regulatory environments; requirements or changes adversely affecting the
health care industry, including changes in Medicare reimbursement policies;
fluctuations in customer demand; management of rapid growth; intensity of
competition; timing, approval and market acceptance of new product
introductions and institutional pharmacy locations; general economic
conditions; geopolitical events and regulatory changes, as well as other
relevant risks detailed in Chem Rx's filings with the Securities and
Exchange Commission. The information set forth herein should be read in
light of such risks. Chem Rx Corporation does not assume any obligation to
update the information contained in this press release.



Contacts: The Ruth Group
Steven C. Silva Investor Relations
President and Chief Operating Stephanie Carrington / Jared Hoffman
Officer (646) 536-7017 / 7013
Chem Rx Corporation scarrington@theruthgroup.com
516-889-8770 jhoffman@theruthgroup.com





See Also

• Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
• Bioscience Career Fair in San Diego Expected to Draw Record Jobseeker Attendance
• Empowering the Disabled to be Proactive
• Speedus Announces Fourth Quarter and Fiscal 2007 Results

Via: Healthcare